Trial Outcomes & Findings for Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study (NCT NCT00852241)
NCT ID: NCT00852241
Last Updated: 2018-03-12
Results Overview
Recruitment status
COMPLETED
Study phase
PHASE4
Target enrollment
18 participants
Primary outcome timeframe
1 year
Results posted on
2018-03-12
Participant Flow
Participant milestones
| Measure |
Restalyne and Perlane
One syringe of Perlane® (1.0cc) and one syringe of Restylane® (1.0cc) will be used total for both tear trough areas.
Restalyne and Perlane: One syringe of Perlane® (1.0cc) and one syringe of Restylane® (1.0cc) will be used total for both tear trough areas.
|
|---|---|
|
Overall Study
STARTED
|
18
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
18
|
Reasons for withdrawal
| Measure |
Restalyne and Perlane
One syringe of Perlane® (1.0cc) and one syringe of Restylane® (1.0cc) will be used total for both tear trough areas.
Restalyne and Perlane: One syringe of Perlane® (1.0cc) and one syringe of Restylane® (1.0cc) will be used total for both tear trough areas.
|
|---|---|
|
Overall Study
Physician Decision
|
18
|
Baseline Characteristics
PI left institution no data is available.
Baseline characteristics by cohort
| Measure |
Restalyne and Perlane
n=18 Participants
One syringe of Perlane® (1.0cc) and one syringe of Restylane® (1.0cc) will be used total for both tear trough areas.
Restalyne: one syringe of Restylane® (1.0cc) will be used total for both tear trough areas.
Perlane: One syringe of Perlane® (1.0cc) will be used total for both tear trough areas.
|
|---|---|
|
Age, Customized
18-70 years
|
0 Participants
PI left institution no data is available.
|
|
Sex/Gender, Customized
female
|
0 Participants
PI left institution, no data is available.
|
PRIMARY outcome
Timeframe: 1 yearPopulation: The Principle Investigator left the institution and no data is available.
Outcome measures
Outcome data not reported
Adverse Events
Restalyne and Perlane
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place